CP
AMRN

Castleview Partners’s Amarin Corp AMRN Stock Holding History

Castleview Partners’s Portfolio AMRN Stock Details AMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-175
Closed -$11K – 763
2022
Q1 		$11K Sell
175
-415
-70% -$27.4K 0.01% 486
2021
Q4 		$3.5K Buy
+590
New +$48.9K 0.03% 203

Other funds holding AMRN

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Castleview Partners's AMRN Position: Q2 2022 in Review

Castleview Partners sold out of Amarin Corp (AMRN) in Q2 2022, closing a stake of 175 shares — an estimated $11K sold.

Castleview Partners first reported a position in AMRN in Q4 2021 and held it in 2 quarters. The position peaked at $11K in Q1 2022. 230 funds tracked by Wall St. Rank hold AMRN as of Q2 2022.

  • Castleview Partners reported no remaining Amarin Corp position as of Q2 2022 after selling out during the quarter.
  • Castleview Partners sold 175 Amarin Corp shares in Q2 2022, an estimated $11K.
  • Castleview Partners first reported a position in Amarin Corp in Q4 2021 and held it in 2 quarters.
  • Castleview Partners's Amarin Corp position peaked at $11K in Q1 2022.
  • 230 funds tracked by Wall St. Rank held Amarin Corp as of Q2 2022.

Based on Castleview Partners's 13F filing for Q2 2022, filed 16 Aug 2022.